Welcure Drugs and Pharmaceuticals Limited received two export sourcing orders worth ₹85.6 crore from Giant Exim and Ravina International for mycorrhizal inoculant. This move will boost margins without inventory risks. The company is also negotiating ₹20 crore in additional orders this quarter and continues to focus on its debt-free, commission-based export business model.